Compare YTRA & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YTRA | TELA |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.2M | 51.2M |
| IPO Year | N/A | 2019 |
| Metric | YTRA | TELA |
|---|---|---|
| Price | $1.82 | $1.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $3.31 |
| AVG Volume (30 Days) | 157.9K | ★ 356.4K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $114,229,876.00 | $77,055,000.00 |
| Revenue This Year | N/A | $18.39 |
| Revenue Next Year | $6.62 | $15.34 |
| P/E Ratio | $290.64 | ★ N/A |
| Revenue Growth | ★ 82.82 | 12.24 |
| 52 Week Low | $0.58 | $0.86 |
| 52 Week High | $2.00 | $3.10 |
| Indicator | YTRA | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 66.95 | 45.98 |
| Support Level | $1.64 | $1.10 |
| Resistance Level | $1.85 | $1.21 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 97.22 | 31.58 |
Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.